Skip to content
Prof. Dr. Mustafa Özdoğan · Medical Oncologist

Misfolded p53 Protein and Cancer

Misfolded p53 Protein and Cancer

Proteins are synthesized as linear amino acid chains and fold to acquire their 3D shapes in order to become active. Protein misfolding and aggregation (clustering) can cause cancer as well as neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease and ALS (amyotrophic lateral sclerosis). Proteins with this incorrect modification that cause disease are defined as prions. While these misfolded, aggregated proteins lead to protein inactivation, aggregates (clusters) can cause toxicity by interfering with intracellular functions or cell-to-cell signals.

Aggregation of misfolded p53 protein

The TP53 gene produces the p53 protein, which is present in all cells and acts as a tumor suppressor. Following DNA damage or other cellular stresses, p53 levels rise as the protein is phosphorylated and stabilized, facilitating DNA repair by pausing the cell cycle or directing damaged cells toward apoptosis.

- Related topic: A New Cellular Pathway Governing p53, the Guardian of the Genome, Has Been Discovered

It has long been known that, in more than 50% of human tumors, p53 mutations have been detected. More recent studies have shown that mutated p53 forms aggregates in tumors and cancer cell lines. It has also been found that p53 aggregates (clusters) spread between cells in a manner similar to the cell-to-cell transmission of prions.

In the mouse experiment, more tumors were detected in mice and patients with p53 mutations and observed aggregation than in those with mutations but no aggregation, and this was associated with the presence of aggregation-prone p53. These findings showed that p53 is a true prionoid and plays an important role in metastasis formation.

The mechanisms underlying aggregation reveal differences among protein misfolding disorders. Aggregates may be intracellular or extracellular and can cause both intracellular and extracellular toxicities.

Targeting p53 aggregation for therapeutic strategies

Findings about the evidence that aggregation of p53, a pronoid, plays an important role in some cancers have paved the way for new therapeutic strategies that specifically interfere with p53 aggregation. Chaperones are another group of heat shock proteins (heast shock proteins) involved in protein folding. As shown in Figure 1, the chaperone complex HSP90-histone deacetylase 6 (HDAC6) has been shown to be upregulated in cancer cells and to stabilize p53 aggregates.

Recently approved HSP90 inhibitors reduced tumor growth and prolonged survival in mice showing an aggregation-prone version of p53. Other p53-deficient mice were not affected by HSP90 inhibitor treatment. In addition, a peptide that binds the amyloid-binding segment of p53 prevents p53 aggregation and restores its function, inducing cell death and tumor regression. It is therefore suggested that the course of cancer treatment depends not only on the identity of a mutated gene but also requires taking the type of mutation into account.

Figure 1: Overexpression of HSP70 and inhibition of HSP90 increase the degradation of misfolded proteins.

degradation of misfolded proteins

Conclusion

From protein synthesis to the point at which proteins acquire their functionally active form, there is still a lack of knowledge about how proteins fold. Beyond this, aggregation of misfolded proteins also leads to further problems.

In cancer, a relationship between p53 protein misfolding and aggregation and cancer metastasis has so far been predicted. In addition, therapeutic options targeting the pathways involved have contributed to regression of metastasis. However, more studies are needed to understand whether these approaches tested in mice work in humans.

Furthermore, in studies of prions, some similarities have also been identified in studies of different protein aggregates. This shows that different aggregates exhibit toxicity through at least partly the same pathways. Together with new technological advances, these findings could allow effective treatments to be developed in the future for all diseases caused by protein misfolding.

Sources

Scheckel C. and Aguzzi A. (30.04.2018). Prions, prionoids and protein misfolding disorders. Nature: https://www.nature.com/

Appointment request

DROZDOGAN AI

Explore this article together

Ask about the article and read answers alongside published sources from our site.

DROZDOGAN AI

Drozdogan Assistant

Misfolded p53 Protein and Cancer

Ask about the article and read answers alongside published sources from our site.

Conversation and privacy information

Drozdogan Assistant answers this conversation. Authorized site administrators may review it for quality. Do not share personal information.

Replies use OpenAI infrastructure. Questions and replies are processed by that service; conversation records are stored on our site. Do not share identifying, contact or personal health information.

0 / 1000

For information only; no personal diagnosis or treatment advice.

Related articles

Explore other articles on this topic.

Stay informed

Receive new articles and scientific updates by email.

Google Analytics runs on public pages independently of this window and may use analytics cookies. Your choice here controls external services only.

Cookie policy